Brimonidine ophthalmic and Mogamulizumab-kpkc
Determining the interaction of Brimonidine ophthalmic and Mogamulizumab-kpkc and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brimonidine ophthalmic
Brand name: Alphagan P, Lumify, Alphagan
Synonyms: Brimonidine (Ophthalmic)
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brimonidine ophthalmic-Mogamulizumab-kpkc Intravenous
- Brimonidine ophthalmic-Molindone
- Brimonidine ophthalmic-Mometasone (Oral Inhalation)
- Brimonidine ophthalmic-Mometasone and Formoterol
- Brimonidine ophthalmic-Mometasone and formoterol Inhalation
- Brimonidine ophthalmic-Mometasone Cream
- Mogamulizumab-kpkc-Brimonidine Tartrate eent
- Mogamulizumab-kpkc-Brimonidine Tartrate topical
- Mogamulizumab-kpkc-Brimonidine topical
- Mogamulizumab-kpkc-Brimonidine Topical application
- Mogamulizumab-kpkc-Brintellix
- Mogamulizumab-kpkc-Brinzolamide